The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc

Spine

Volumn 33, Issue 24, 2008, Pages 2586-2595

  Li, Xin ^a   Phillips, Frank M ^a   An, Howard S ^a   Ellman, Michael ^a   Thonar, Eugene J ^a,b   Wu, William ^c   Park, Daniel ^a   Im, Hee Jeong ^a,b  

^a Department of Biochemistry ^*  (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

Anabolic; Intervertebral disc degeneration; MMP 13; Regeneration; Resveratrol

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGENASE 3; INTERLEUKIN 1; METALLOPROTEINASE; OSTEOGENIC PROTEIN 1; PROTEIN ADAMTS 4; PROTEOGLYCAN; RESVERATROL; UNCLASSIFIED DRUG; ADAM PROTEIN; AGGRECANASE 1; AGGRECANASE-1; FIBROBLAST GROWTH FACTOR 2; PHYTOESTROGEN; PROCOLLAGEN N PROTEINASE; STILBENE DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE REGENERATION; BONE REMODELING; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GLYCOPROTEIN SYNTHESIS; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS PULPOSUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEOGLYCAN SYNTHESIS; ANIMAL; ARTICULAR CARTILAGE; CATTLE; DNA REPLICATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; FRUIT; GENE EXPRESSION REGULATION; GENETICS; GRAPE; HOMEOSTASIS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME;

ADAM PROTEINS; ANIMALS; CARTILAGE, ARTICULAR; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; FRUIT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; INTERLEUKIN-1; INTERVERTEBRAL DISK; MATRIX METALLOPROTEINASE 13; PHYTOESTROGENS; PROCOLLAGEN N-ENDOPEPTIDASE; PROTEOGLYCANS; SIGNAL TRANSDUCTION; STILBENES; TIME FACTORS; VITIS;

EID: 58949092349     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181883883     Document Type: Article

References (49)

1. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999;354:581-5.
2. Mooney V. The classification of low back pain. Ann Med 1989;21:321-5.
3. Freemont TJ, LeMaitre C, Watkins A, et al. Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapies. Expert Rev Mol Med 2001;2001:1-10.
4. Abe Y, Akeda K, An HS, et al. Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine 2007;32:635-42.
5. An HS, Thonar EJ, Masuda K. Biological repair of intervertebral disc. Spine 2003;28:S86-92.
6. An H, Boden SD, Kang J, et al. Summary statement: emerging techniques for treatment of degenerative lumbar disc disease. Spine 2003;28:S24 -5.
7. Zhang Y, An HS, Song S, et al. Growth factor osteogenic protein-1: differing effects on cells from three distinct zones in the bovine intervertebral disc. Am J Phys Med Rehabil 2004;83:515-21.
8. Buckwalter JA, Kuettner KE, Thonar EJ. Age-related changes in articular cartilage proteoglycans: electron microscopic studies. J Orthop Res 1985;3: 251-7.
9. Iannone F, Lapadula G. The pathophysiology of osteoarthritis. Aging Clin Exp Res 2003;15:364-72.
10. Le Maitre CL HJ, Freemont AJ. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther 2007;9:R77.
11. Shinmei M, Kikuchi T, Yamagishi M, et al. The role of interleukin-1 on proteoglycan metabolism of rabbit annulus fibrosus cells cultured in vitro. Spine 1988;13:1284-90.
12. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004;204:47-54.
13. Im HJ, Muddasani P, Natarajan V, et al. Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cdelta pathways in human adult articular chondrocytes. J Biol Chem 2007;282:11110-21.
14. Salminen HJ, Saamanen AM, Vankemmelbeke MN, et al. Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model. Ann Rheum Dis 2002;61:591-7.
15. Smeets TJ, Barg EC, Kraan MC, et al. Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 2003;62:635-8.
16. Pendas AM, Uria JA, Jimenez MG, et al. An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta 2000;291:137-55.
17. Powell AJ, Little CB, Hughes CE. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggre-can in a porcine chondrocyte culture system. Arthritis Rheum 2007;56: 3010-9.
18. Miwa HE, Gerken TA, Hering TM. Effects of covalently attached chon-droitin sulfate on aggrecan cleavage by ADAMTS-4 and MMP-13. Matrix Biol 2006;25:534-45.
19. Haider UG, Sorescu D, Griendling KK, et al. Resveratrol suppresses angio- tensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 2002;62:772-7.
20. Bhat KPL, Kosmeder JW II, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001;3:1041-64.
21. Bertelli AA, Ferrara F, Diana G, et al. Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity. Int J Tissue React 1999;21:93-104.
22. Fremont L. Biological effects of resveratrol. Life Sci 2000;66:663-73.
23. Huang KS, Lin M, Cheng GF. Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes. Phytochemistry 2001;58:357-62.
24. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of res-veratrol, a natural product derived from grapes. Science 1997;275:218-20.
25. Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000;59:865-70.
26. Ignatowicz E, Baer-Dubowska W. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol J Pharmacol 2001;53:557-69.
27. Leiro J, Alvarez E, Arranz JA, et al. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J Leukoc Biol 2004;75:1156-65.
28. Wang Z, Huang Y, Zou J, et al. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 2002; 9:77-9.
29. Orallo F, Alvarez E, Camina M, et al. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 2002;61:294-302.
30. Elmali N, Esenkaya I, Harma A, et al. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 2005;54:158-62.
31. Elmali N, Baysal O, Harma A, et al. Effects of resveratrol in inflammatory arthritis. Inflammation 2007;30:1-6.
32. Loeser RF, Chubinskaya S, Pacione C, et al. Basic fibroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes. Arthritis Rheum 2005;52: 3910-7.
33. Loeser RF, Todd MD, Seely BL. Prolonged treatment of human osteoarthritic chondrocytes with insulin-like growth factor-I stimulates proteoglycan synthesis but not proteoglycan matrix accumulation in alginate cultures. J Rheumatol 2003;30:1565-70.
34. Im HJ, Pacione C, Chubinskaya S, et al. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and in-terleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 2003;278:25386-94.
35. Hauselmann HJ, Aydelotte MB, Schumacher BL, et al. Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix 1992;12:116-29.
36. Gruber HE, Hoelscher GL, Leslie K, et al. Three-dimensional culture of human disc cells within agarose or a collagen sponge: assessment of proteo-glycan production. Biomaterials 2006;27:371-6.
37. Im HJ, Li X, Muddasani P, et al. Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J Cell Physiol 2007.
38. Muddasani P, Norman JC, Ellman M, et al. Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J Biol Chem 2007;282:31409-21.
39. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
40. Loeser RF, Shanker G, Carlson CS, et al. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 2000;43:2110-20.
41. Lindy O, Konttinen YT, Sorsa T, et al. Matrix metalloproteinase 13 (colla-genase 3) in human rheumatoid synovium. Arthritis Rheum 1997;40: 1391-9.
42. Raggatt LJ, Jefcoat SC Jr, Choudhury I, et al. Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes. Osteoarthritis Cartilage 2006;14:680-9.
43. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integrationof complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002;4:157-64.
44. Yammani RR, Carlson CS, Bresnick AR, et al. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. Arthritis Rheum 2006;54:2901-11.
45. Inada M, Wang Y, Byrne MH, et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA 2004;101:17192-7.
46. Kundu JK, Surh YJ. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 2004;555:65-80.
47. Roberts S. Disc morphology in health and disease. Biochem Soc Trans 2002; 30:864-9.
48. Lee MK, Kang SJ, Poncz M, et al. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 2007;39: 376-84.
49. Shakibaei M, John T, Seifarth C, et al. Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann N Y Acad Sci 2007;1095:554-63.